Saturday, December 2, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from
Janssen Pharmaceuticals, Inc.
Rapid Fire
Serving Up Prevention for CAD/CVD!
New Challenge
New Challenge
New Challenge
Co-Chair
President, Society for Vascular Medicine
Professor of Medicine, Michigan State University College of Human Medicine
Medical Director, Heart & Vascular Services
Benson Ford Chair in Cardiology
Henry Ford Health
Detroit, Michigan
Co-Chair
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI (Co-chair)
Director of Mount Sinai Heart
Dr. Valentin Fuster Professor of Cardiovascular Medicine
Icahn School of Medicine at Mount Sinai Health System
New York, New York
Associate Professor of Internal Medicine
Vascular and Cardiovascular Medicine
Director, Vascular Medicine Fellowship
Frankel Cardiovascular Center
Co-Director, Michigan Program on Value Enhancement (MPrOVE)
Co-Director, Michigan Anticoagulation Quality Improvement Initiative (MAQI2)
Holder of the James O Wolliscroft Early Career Endowment Award
University of Michigan
Ann Arbor, Michigan
Associate Professor of Medicine
Director Vascular Research
University of Colorado School of Medicine
Executive Director; CPC Clinical Research
Aurora, Colorado
Assistant Professor of Medicine (Vascular Medicine)
Program Director, Vascular Medicine Fellowship
Zena and Michael A. Wiener Cardiovacular Institute and Marie-Josée
and Henry R. Kravis Center for Cardiovascular Health
Icahn School of Medicine at Mount Sinai
New York, New York
Director, Samuel A. Levine Cardiac Intensive Care Unit
Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Cardiovascular Division
Brigham and Women's Hospital
Boston, Massachusetts
Richard S. Stack Distinguished Professor
Chief, Division of Cardiology
Co-Director Duke Heart Center
Duke Clinical Research Institute
Duke University
Durham, North Carolina
Co-Chair
Has the following relevant financial relationships:
Consultant or advisor for: Philips; Silk Road Medical
Co-Chair
Has the following relevant financial relationships:
Consultant or advisor for: Angiowave; Bayer; Boehringer Ingelheim Pharmaceuticals, Inc.; Broadview Ventures; Cardax; CellProthera; Cereno Scientific; High Enroll; Hims, Inc.; Janssen; Level Ex; McKinsey & Company; Merck; MyoKardia; NirvaMed; Novo Nordisk; PhaseBio Pharmaceuticals, Inc.; PLx Pharma Inc.; Regado Biosciences; Stasys
Research funding from: Abbott; Acesion Pharma; Afimmune; Aker Biomarine; Amarin Corporation plc; Amgen Inc.; AstraZeneca; Bayer; Beren; Boehringer Ingelheim Pharmaceuticals, Inc.; Boston Scientific; Bristol Myers Squibb Company; Cardax; CellProthera; Cereno Scientific; Chiesi; CinCor; Cleerly; CSL Behring; Eisai Inc.; Ethicon; Faraday Pharmaceuticals; Ferring Pharmaceuticals; Forest Laboratories, Inc.; Fractyl Laboratories, Inc.; Garmin; HLS Therapeutics; Idorsia Pharmaceuticals, Ltd.; Ironwood Pharmaceuticals, Inc.; Ischemix, Inc., Inc.; Janssen; Javelin; Lexicon Pharmaceuticals, Inc.; Lilly; Medtronic, Inc.; Merck; Moderna, Inc.; MyoKardia; NirvaMed; Novartis; Novo Nordisk; Owkin; Pfizer, Inc.; PhaseBio Pharmaceuticals, Inc.; PLx Pharma Inc.; Recardio; Regeneron Pharmaceuticals, Inc.; Roche; Sanofi; Stasys; Synaptic Pharmaceutical Corporation; The Medicines Company; Youngene; 89Bio
Contracted researcher for: Abbott; Biotronik; Boston Scientific; CSI; Endotronix; St. Jude Medical (now Abbott); Philips; SpectraWAVE; Svelte; Vascular Solutions, Inc.
Patent beneficiary of: Sotagliflozin
Stock options from: Angiowave; DRS.LINQ
Owns stock (privately owned) in: High Enroll
Owns stock (publicly traded) in: Bristol Myers Squibb Company
Other: Board of Directors: Angiowave; Bristol Myers Squibb Company; DRS.LINQ; High Enroll; TobeSoft; Data Safety Monitoring Committees: Acesion Pharma; Boston Scientific; Contego Medical; Novartis
Has the following relevant financial relationships:
Consultant or advisor for: Abbott Vascular; Bayer; Boston Scientific; Bristol Myers Squibb Company; Janssen; Pfizer, Inc.
Research funding from: Boston Scientific
Other: Board of Directors for the Anticoagulation Forum
has the following relevant financial relationships:
Consultant or advisor for: Abbott; Agios Pharmaceuticals; Alexion Pharmaceuticals, Inc.; Alnylam Pharmaceuticals, Inc; Amgen Inc.; Angionetics; Anthos Therapeutics; ARCA Biopharma; Array BioPharma; AstraZeneca; Audentes; Bayer; Better Therapeutics; Bristol Myers Squibb Company; Cardiol Therapeutics; CellResearch; Cook Medical; Cook Regentec; CSL Behring; Eidos Therapeutics; EP Trading Co; EPG Communications; Epizon Pharma; Esperion Therapeutics, Inc.; EverlyWell; Faraday; Fortress Biotech; HDL Therapeutics; Hummingbird Bioscience; Insmed Incorporated; Janssen Biotech, Inc.; Kowa Research; Lexicon Pharmaceuticals, Inc.; Medtronic, Inc.; Merck; Moderna, Inc.; Novate Medical; Novo Nordisk; Pfizer, Inc.; PhaseBio Pharmaceuticals, Inc.; PPD Development; Prothena Biosciences; Regeneron Pharmaceuticals, Inc.; Regio Biosciences; Sanifit Therapeutics; Sanofi; Silence Therapeutics; Stealth BioTherapeutics; VarmX; Wraser
Research funding from: Abbott; Agios Pharmaceuticals; Alexion Pharmaceuticals, Inc.; Alnylam Pharmaceuticals, Inc; Amgen Inc.; Angionetics; Anthos Therapeutics; ARCA Biopharma; Array BioPharma; AstraZeneca; Audentes; Bayer; Better Therapeutics; Bristol Myers Squibb Company; Cardiol Therapeutics; CellResearch; Cook Medical; Cook Regentec; CSL Behring; Eidos Therapeutics; EP Trading Co; EPG Communications; Epizon Pharma; Esperion Therapeutics, Inc.; EverlyWell; Faraday; Fortress Biotech; HDL Therapeutics; Hummingbird Bioscience; Insmed Incorporated; Janssen Biotech, Inc.; Kowa Research; Lexicon Pharmaceuticals, Inc.; Medtronic, Inc.; Merck; Moderna, Inc.; Novate Medical; Novo Nordisk; Pfizer, Inc.; PhaseBio Pharmaceuticals, Inc.; PPD Development; Prothena Biosciences; Regeneron Pharmaceuticals, Inc.; Regio Biosciences; Sanifit Therapeutics; Sanofi; Silence Therapeutics; Stealth BioTherapeutics; VarmX; Wraser
Owns stock (publicly traded) in: Medtronic, Inc.; Pfizer, Inc.
Has the following relevant financial relationships
Speaker or member of speakers bureau for: Abbott Laboratories; Boston Scientific
Research funding from: Philips Healthcare, Inc.
Has the following relevant financial relationships:
Consultant or advisor for: Abbott Laboratories; ARCA Biopharma; InCarda Therapeutics, Inc.; Inflammatix; Merck; Novartis; Roche Diagnostics
Research funding from: Abbott Laboratories; ABIOMED; Amgen Inc.; Anthos Therapeutics; ARCA Biopharma; AstraZeneca; Daiichi Sankyo, Inc.; Intarcia Therapeutics, Inc.; Janssen Biotech, Inc.; Merck; Novartis; Pfizer, Inc.; Poxel SA; Quark Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Inc.; Roche; Siemens Healthcare Diagnostics Inc.; Zora Biosciences
Has the following relevant financial relationships:
Consultant or advisor for: Bayer; Janssen Biotech, Inc.; Novartis
Research funding from: Bayer; HeartFlow; Janssen Biotech, Inc.; Novartis